Paroxysmal Cold Hemoglobinuria Latest Advances
Find the Latest Research About Paroxysmal Cold Hemoglobinuria
Last Updated: 06/30/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 4553 publications
Real-world pegcetacoplan treatment of paroxysmal nocturnal hemoglobinuria patients with an unsatisfactory response to prior therapies.
Journal: Hematology (Amsterdam, Netherlands)
Published: June 11, 2026
Response to "Comment on 'Consensus of the hematology society of Taiwan on the management of paroxysmal nocturnal hemoglobinuria (PNH)'".
Journal: Journal of the Formosan Medical Association = Taiwan yi zhi
Published: June 08, 2026
Complement C5 inhibitor crovalimab for the treatment of paroxysmal nocturnal hemoglobinuria.
Journal: Expert review of clinical pharmacology
Published: May 29, 2026
Comment on "Consensus of the hematology society of Taiwan on the management of paroxysmal nocturnal hemoglobinuria (PNH)".
Journal: Journal of the Formosan Medical Association = Taiwan yi zhi
Published: May 21, 2026
Efficacy and Safety of the C3 Inhibitor Pegcetacoplan in Paroxysmal Nocturnal Hemoglobinuria: A Systematic Review and Meta-Analysis.
Journal: European journal of haematology
Published: May 04, 2026
Clonal Selection and Evolution after Treatment of Severe Aplastic Anemia.
Journal: NEJM evidence
Published: April 28, 2026
Efficacy and Safety of Treatments for Paroxysmal Nocturnal Hemoglobinuria: A Systematic Literature Review.
Journal: Journal of clinical medicine
Published: March 26, 2026
Case report: persistent anemia after eculizumab in paroxysmal nocturnal hemoglobinuria: non-dominantly active intravascular hemolysis.
Journal: Hematology (Amsterdam, Netherlands)
Published: March 20, 2026
Indirect treatment comparison of iptacopan versus pegcetacoplan for patients with paroxysmal nocturnal hemoglobinuria and residual anemia despite C5 inhibitor treatment.
Journal: Journal of comparative effectiveness research
Published: March 19, 2026
Decrease in PNH-type Blood Cells after the Cessation of Thrombopoietin Receptor Agonist in a Case of AA-PNH Syndrome.
Journal: Internal medicine (Tokyo, Japan)
Published: March 18, 2026
The Challenges Associated with the Diagnosis and Treatment for Aplastic Anemia Concurrent with Lymphoplasmacytic Lymphoma/Waldenström's Macroglobulinemia.
Journal: Internal medicine (Tokyo, Japan)
Published: March 11, 2026
Last Updated: 06/30/2026